LeonardRJNystromJS. Diagnostic evaluation of patients with carcinoma of unknown primary tumor site. Semin Oncol1993;20:244–50.
2.
HaskellCMCochranAJBarskySH. Metastasis of unknown origin. Curr Probl Cancer1988;12:5–57.
3.
NissenblattMR. The CUP syndrome (carcinoma of unknown primary). Cancer Treat Rev1981;8:211–24.
4.
AltmannECadmannE. An analysis of 1539 patients with cancer of unknown primary site. Cancer1986;57:120–4.
5.
SmithPEKrementzETChapmanW. Metastatic cancer without a detectable site. Am J Surg1967;113:633–7.
6.
SteckelRJKaganAR. Diagnostic persistence in working up metastatic cancer with an unknown primary site. Radiology1980;134:367–9.
7.
CokerDDCasterlinePFChambersRG. Metastases to the lymph nodes of the head and neck from an unknown primary site. Am J Surg1977;134:517–22.
8.
BailetJWAbemayorEJabourBAHawkinsRAHoCWardPH. Positron emission tomography: A new, precise imaging modality for detection of primary head and neck tumors and assessment of cervical adenopathy. Laryngoscope1992;102:281–8.
9.
JungehuelsingMScheidhauerK. FDG-PET im Vergleich mit CT, MRT, und Sonographie zum Staging von Kopf-, Hals-Plattenepithelkarzinomen. Eur Arch Otorhinolaryngol1994;11:171–2.
MedinaJE. A rational classification of neck dissections. Otolaryngol Head Neck Surg1989;100:169–76.
12.
AbbruzzeseJL. An effective strategy for the evaluation of unknown primary tumors. Cancer Bull1989;41:157–61.
13.
LefebvreJLCoche-DequeantBTon VanJBuissetEAdenisA. Cervical lymph nodes from an unknown primary tumor in 190 patients. Am J Surg1990;160:443–6.
14.
MancusoAHarnsbergerHMurakiA. Computed tomography of cervical and retropharyngeal lymph nodes: Normal anatomy, variants of normal, and applications in head and neck cancer. Radiology1983;148:709–23.
15.
van den BrekelMCastelijnsJStelH. Detection and characterization of metastatic cervical adenopathy by MR imaging. Comparison of different MR techniques. J Comput Assist Tomogr1990;14:581–9.
16.
DaugaardG. Unknown primary tumours. Cancer Treat Rev1994;20:119–47.
17.
HainsworthJDGrecoAF. Managing carcinomas of unknown primary site. Oncology (Huntingt)1988;2:43–9.
18.
AbbruzzeseJLAbbruzzeseMCLenziRHessKRRaberMN. Analysis of a diagnostic strategy for patients with suspected tumors of unknown origin. J Clin Oncol1995;13:2094–103.
19.
WilsonCBJH. PET scanning in oncology. Eur J Cancer1992;28:508–10.
20.
MejiaAANakamuraTMasatoshiIHatazawaJMasakiMWatanukiS. Estimation of absorbed doses in humans due to intravenous administration of fluorine-18-fluorodeoxy-glucose in PET studies. J Nucl Med1991;32:699–706.
21.
SchipperJHSchraderMArweilerDMüllerSSciukJ. Positron emission tomography to locate primary tumor in patients with cervical lymph node metastases from an occult tumor. HNO1996;44:254–7.
